Michaela Nikolaou

Dr. Michaela Nikolaou

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 July 2023 in Hormones
Verified
Journal Article
Closed access
PDF file
MNMichaela Nikolaou
Michaela Nikolaou
IVIoannis-Anargyros Vasilakis
Ioannis-Anargyros Vasilakis
NMNikolaos M. Marinakis
Nikolaos M. Marinakis
FTFaidon-Nikolaos Tilemis
Faidon-Nikolaos Tilemis
AZAglaia Zellos
Aglaia Zellos
CKChristina Kanaka-Gantenbein
Christina Kanaka-Gantenbein

20 August 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
EKEftychia G. Koukkou
Eftychia G. Koukkou
PGPanagiotis Girginoudis
Panagiotis Girginoudis
MNMichaela Nikolaou
Michaela Nikolaou
ATAnna Taliou
Anna Taliou
ATAlexandra Tsigkri
Alexandra Tsigkri
KMKostas B Markou
Kostas B Markou
Background/Objectives: Neonatal screening programmes for thyroid function testing, based on Thyroid Stimulating Hormone (TSH) assessment, detect not only Permanent Congenital Hypothyroidism (PCH), but also Transient Congenital Hypothyroidism (TCH). In Greece, newborn screening for congenital hypothyroidism (CH), using TSH measurement in dried blood spots (Guthrie card), began in 1979 through the Institute of Child Health (ICH). Although the general Greek population is considered iodine-replete, most pregnant Greek women are mildly iodine-deficient according to WHO criteria. The aim of this retrospective study was to record the cases of TCH and the main causative factor over a 10-year period (2010–2019) in Greece, when the country was iodine-replete. Methods: The number of births in Greece between 2010 and 2019 were retrieved from the Hellenic Statistical Authority (ELSTAT) archives reaching 952,109 births, while the total number of newborns assessed through the ICH was 951,342 (99%). During this period, 22,391 newborns were detected with TSH >7 mIU/L after the second check on the initial Guthrie card. Among those, 17,992 underwent re-testing with a serum sample. Out of the re-tested newborns, 1,979 were screened positive for Congenital Hypothyroidism (CH) and immediately began treatment with levothyroxine. We followed up with families, paediatricians, and paediatric endocrinologists to determine whether L-thyroxine therapy had been successfully discontinued for at least two months after the child’s third birthday. Successful contact was achieved with 889 individuals. From this group, 329 children had successfully discontinued thyroxine, classified as TCH. The remaining 560 cases were considered to have PCH. Demographic data, including gender, gestational age, and birth weight, were collected from the archives of the ICH. Maternal data, including thyroid medication use and the presence of elevated thyroid autoantibodies during pregnancy and childbirth, were also recorded. Newborns were categorized as full-term or premature. To identify TCH cases not influenced by maternal factors during gestation, such as medication use or elevated thyroid autoantibodies, we have excluded these cases, defining the Target Group of our study. Results: Logistic regression analysis revealed that, while controlling for all other predictor variables, the odds ratio of transient hypothyroidism was 2.078 (95% CI: 1.530 to 2.821, p = 0.001) for prematurely born children compared to those born at term. The effect of other factors on TCH versus PCH was not significant. ANOVA indicated an interaction between prematurity or permanent hypothyroidism and birthweight centile (F = 7.861 & 5.205, p = 0.005 & 0.023, respectively). Conclusions: Prematurity is the main factor for Transient Congenital Hypothyroidism in a recently iodine-replete country, such as Greece.

24 September 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
EKEftychia G. Koukkou
Eftychia G. Koukkou
PGPanagiotis Girginoudis
Panagiotis Girginoudis
MNMichaela Nikolaou
Michaela Nikolaou
ATAnna Taliou
Anna Taliou
ATAlexandra Tsigkri
Alexandra Tsigkri
KMKostas B Markou
Kostas B Markou
Background/Objectives: Neonatal screening programmes for thyroid function testing, based on thyroid-stimulating hormone (TSH) assessment, detect both Permanent Congenital Hypothyroidism (PCH) and Transient Congenital Hypothyroidism (TCH). Maternal iodine-deficient dietary intake may result in compensatory neonatal TSH elevation; screening for Congenital Hypothyroidism (CH) is used as an indicator of the degree of iodine deficiency and of its control. In Greece, newborn screening for CH, using TSH measurement in dried blood spots (Guthrie card), began in 1979 through the Institute of Child Health (ICH). Although the general Greek population is considered iodine-replete, most pregnant Greek people are mildly iodine deficient according to the stricter WHO criteria. The aim of this retrospective study was to record the cases of TCH and the main causative factors over a 10-year period (2010–2019) in Greece, when the country was deemed to be iodine-replete. Methods: The number of births in Greece between 2010 and 2019 was retrieved from the Hellenic Statistical Authority (ELSTAT) archives: 952,109 births were recorded. The total number of newborns assessed through the ICH was 951,342 (99%). During this period, 22,391 newborns were identified to have TSH > 7 mIU/L after the second check on the initial card. Among those, 17,992 underwent retesting with a serum sample. Out of the retested newborns, 1979 were screened positive for CH and immediately began treatment with levothyroxine. We followed up with families, paediatricians, and paediatric endocrinologists to determine whether L-thyroxine therapy had been successfully discontinued for at least two months after the child’s third birthday. Successful contact was achieved with 889 individuals. From this group, 329 children had successfully discontinued thyroxine, classified as TCH. Demographic data, including gender, gestational age, and birth weight, were collected from the archives of the ICH. Maternal data, including thyroid medication use and the presence of elevated thyroid autoantibodies during pregnancy and childbirth, were also recorded. Results: Logistic regression analysis revealed that, while controlling for all other predictor variables, the odds ratio of transient hypothyroidism was 2.078 (95% CI: 1.530 to 2.821) for prematurely born children compared to those born at term. The effects of other factors on TCH versus PCH were not significant. Conclusions: It seems that prematurity is the main factor contributing to Transient Congenital Hypothyroidism in Greece, a recently iodine-replete country.